Bortezomib, free base, 100mg

Bortezomib, free base, 100mg 

To Order Contact us: lieven@wlsolutions.be

gel casting base for evs3300

EVS3300-BASE ea
EUR 361.2

Rapamycin, 100mg

R5312-100mg
EUR 902.4

Doxorubicin HCl, 100mg

R2531-100mg
EUR 1560

Cyclosporin A, 100mg

R5986-100mg
EUR 228

Vatalanib, Free Base

2026-25
EUR 366

Vatalanib, Free Base

2026-5
EUR 151.2

Erlotinib, Free Base

2048-100
EUR 189.6

Erlotinib, Free Base

2048-1000
EUR 464.4

Sunitinib, Free base

2097-100
EUR 229.2

Sunitinib, Free base

2097-1000
EUR 601.2

Sunitinib, Free base

2097-25
EUR 138

Ruxolitinib (free base)

10-042 25 mg
EUR 418.2
Description: Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19).

Lapatinib, Free base

2138-100
EUR 464.4

Lapatinib, Free base

2138-25
EUR 229.2

Ruxolitinib, Free base

2139-100 Ask for price

Ruxolitinib, Free base

2139-25
EUR 639.6

Ruxolitinib, Free base

2139-5
EUR 248.4

Imatinib, Free base

2141-100
EUR 176.4

Imatinib, Free base

2141-1000
EUR 502.8

Linsitinib, Free base

2294-25
EUR 679.2

Linsitinib, Free base

2294-5
EUR 222

Tipifarnib, Free base

2296-1
EUR 170.4

Tipifarnib, Free base

2296-5
EUR 496.8

Rucaparib (free base)

A8893-10 10 mg
EUR 240
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)

A8893-200 200 mg
EUR 1243.2
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)

A8893-5 5 mg
EUR 164.4
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)

A8893-5.1 10 mM (in 1mL DMSO)
EUR 170.4
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)

A8893-50 50 mg
EUR 547.2
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

LY2835219 free base

A3575-100 100 mg
EUR 686.4
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

LY2835219 free base

A3575-25 25 mg
EUR 309.6
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

LY2835219 free base

A3575-5 5 mg
EUR 170.4
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

R406 (free base)

A5880-100 100 mg
EUR 1452
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-25 25 mg
EUR 616.8
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-5 5 mg
EUR 199.2
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-5.1 10 mM (in 1mL DMSO)
EUR 316.8
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-S Evaluation Sample
EUR 97.2
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

THZ1 (Free base)

9664-25
EUR 1227.6

THZ1 (Free base)

9664-5
EUR 352.8

MCC950 (Free base)

B1031-1
EUR 183.6

MCC950 (Free base)

B1031-5
EUR 548.4

FIPI (free base)

B2372-25
EUR 757.2

FIPI (free base)

B2372-5
EUR 235.2

Terbinafine (Free base)

B2423-250
EUR 248.4

Terbinafine (Free base)

B2423-50
EUR 144

PLX5622 (free base)

B2965-25 25 mg
EUR 903.6

PLX5622 (free base)

B2965-5 5 mg
EUR 272.4

Apatinib (Free base)

B1613-25
EUR 496.8

Apatinib (Free base)

B1613-5
EUR 170.4

Carubicin (Free base)

B1853-1
EUR 183.6

Carubicin (Free base)

B1853-5
EUR 548.4

AZD4547, Free Base

ADC-P-063 unit Ask for price

AZD8055, Free Base

ADC-P-064 unit Ask for price

Cyclopamine, Free Base

ADC-P-079 unit Ask for price

Ixabepilone, Free Base

ADC-P-104 unit Ask for price

R406(free base)

E1KS1533 2mg
EUR 625.2

Ripasudil free base

HY-15685A 10mg
EUR 489.6

Vatalanib (free base)

HY-10203 5mg
EUR 142.8

RPR107393 free base

HY-100299 1mg
EUR 577.2

FR167344 free base

HY-100301 1mg
EUR 3164.4

FR183998 free base

HY-100302 1mg
EUR 1352.4

FR194738 free base

HY-100303 1mg
EUR 2388

YM158 (free base)

HY-U00355 1mg
EUR 2770.8

Masupirdine (free base)

HY-109118 1mg
EUR 267.6

R406 (free base)

HY-11108 10mM/1mL
EUR 277.2

ITI214 (free base)

HY-12501 100mg
EUR 3531.6

AS2863619 (free base)

HY-126675 5mg
EUR 1410

AZD3839 (free base)

HY-13438 50mg
EUR 1216.8

TMB free base

TB0954 1g
EUR 85.06

Xylazine (free base)

Q-1445.0025 25.0g
EUR 385.2
Description: Sum Formula: C12H16N2S; CAS# [7361-61-7]

Biotin-X, free acid:100mg

90053 100MG
EUR 158.4
Description: Minimum order quantity: 1 unit of 100MG

Bioin-XX, free acid: (100mg)

90054 100MG
EUR 258
Description: Minimum order quantity: 1 unit of 100MG

RGB-286638,  free base

2886-25
EUR 907.2

RGB-286638,  free base

2886-5
EUR 274.8

GSK-J4 (Free base)

2762-1
EUR 144

GSK-J4 (Free base)

2762-5
EUR 314.4

StemRegenin 1, Free base

2642-1
EUR 157.2

StemRegenin 1, Free base

2642-5
EUR 398.4

AM-095 free base

A3167-10 10 mg
EUR 254.4
Description: AM095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (LPA1) with IC50 values of 0.73 and 0.98 ?M for mouse or recombinant human LPA1, respectively [1].

AM-095 free base

A3167-100 100 mg
EUR 964.8
Description: AM095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (LPA1) with IC50 values of 0.73 and 0.98 ?M for mouse or recombinant human LPA1, respectively [1].

AM-095 free base

A3167-200 200 mg
EUR 1382.4
Description: AM095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (LPA1) with IC50 values of 0.73 and 0.98 ?M for mouse or recombinant human LPA1, respectively [1].

AM-095 free base

A3167-5 5 mg
EUR 199.2
Description: AM095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (LPA1) with IC50 values of 0.73 and 0.98 ?M for mouse or recombinant human LPA1, respectively [1].

AM-095 free base

A3167-50 50 mg
EUR 686.4
Description: AM095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (LPA1) with IC50 values of 0.73 and 0.98 ?M for mouse or recombinant human LPA1, respectively [1].

Bortezomib, free base, 100mg